Interferó beta 1a (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Interferó beta 1a" in Catalan language version.

refsWebsite

Global rank Catalan rank

4^th place

7^th place

2^nd place

6^th place

1^st place

216^th place

204^th place

about.com

Stachowiak PhD., Julie. «Is Avonex Right for You?», 2008. Arxivat de l'original el 2016-03-03. [Consulta: 7 maig 2008].

Murdoch D, Lyseng-Williamson KA «Spotlight on subcutaneous recombinant interferon-beta-1a (Rebif) in relapsing-remitting multiple sclerosis». BioDrugs, 19, 5, 2005, pàg. 323–5. DOI: 10.2165/00063030-200519050-00005. PMID: 16207073.
Kieseier, Bernd C. «The Mechanism of Action of Interferon-β in Relapsing Multiple Sclerosis». CNS Drugs, 25, 6, 01-06-2011, pàg. 491–502. DOI: 10.2165/11591110-000000000-00000. PMID: 21649449.
Bates, D «Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials.». Neurology, 76, 1 Suppl 1, 04-01-2011, pàg. S14-25. DOI: 10.1212/WNL.0b013e3182050388. PMID: 21205678.

Murdoch D, Lyseng-Williamson KA «Spotlight on subcutaneous recombinant interferon-beta-1a (Rebif) in relapsing-remitting multiple sclerosis». BioDrugs, 19, 5, 2005, pàg. 323–5. DOI: 10.2165/00063030-200519050-00005. PMID: 16207073.
«Long-term follow-up of clinical trials of multiple sclerosis therapies.» (en anglès). [Consulta: 19 desembre 2013].
Kieseier, Bernd C. «The Mechanism of Action of Interferon-β in Relapsing Multiple Sclerosis». CNS Drugs, 25, 6, 01-06-2011, pàg. 491–502. DOI: 10.2165/11591110-000000000-00000. PMID: 21649449.
Bates, D «Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials.». Neurology, 76, 1 Suppl 1, 04-01-2011, pàg. S14-25. DOI: 10.1212/WNL.0b013e3182050388. PMID: 21205678.

Stachowiak PhD., Julie. «Is Avonex Right for You?», 2008. Arxivat de l'original el 2016-03-03. [Consulta: 7 maig 2008].